Ebola Bundibugyo Hits Congo, Testing Gaps Keep It Out of Sight

The Bundibugyo strain of Ebola has triggered a rapid and unprecedented outbreak in the Democratic Republic of Congo (DRC), eclipsing all previous cases.

• Infections: Over 1,100 since mid‑May
• Deaths: Nearly 300, the highest ever for this strain
• Neighboring impact: Uganda reports a few dozen cases and several fatalities

Why the surge is alarming

• Detection challenges: Standard lab tests focus on the Zaire strain; Bundibugyo can evade early detection.
• No specific countermeasures: No approved vaccine or treatment exists yet, though trials will start soon.
• Milder early symptoms: Fever, vomiting, and diarrhea—common to malaria—mask the disease, delaying care.
• Low bleeding incidence: Only ~10 % of confirmed patients bleed compared to 40 % in other outbreaks, sowing confusion and mistrust.
• Security threats: Violence against medical teams hampers testing, isolation, and treatment.

Response strategy

1. Rapid testing – deploy portable diagnostics to catch cases early.
2. Isolation – secure facilities for infected patients, even in conflict zones.
3. Supportive care – focus on hydration and symptom management.

The war‑torn setting amplifies the risk of overwhelming health systems, underscoring the need for international aid and local cooperation to curb the spread.